What is LOPJLB’s current signal on IFRX?

LOPJLB’s latest quantitative signal on InflaRx N.V. (IFRX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is IFRX in?

InflaRx N.V. (IFRX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does InflaRx N.V. (IFRX) do?

InflaRx N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States. The company's focus on C5a stems from its critical role as an inflammatory mediator implicated in the progression of various autoimmune and inflammatory diseases. Its primary product candidate, vilobelim…

InflaRx N.V. (IFRX)

COMPARE

Healthcare · Biotechnology · NASDAQ · DE

$1.48-4.52%Close

SELLCRISIS · day 15

[SCORES & PROFILE]

FUND: 26
VALUE: 11
GROWTH: 77
GARP: 11
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-34.8%

REV YoY-

ROE-58.0%

EPS YoY-

ROA-23.5%

GROSS

48202

362271

NET

387532

[VALUATION]

P/E TTM-2.70

P/E FWD-

SECTOR PE20.48

INDUSTRY PE13.99

P/B1.06

P/FCF-

EV/EBITDA-1.27

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E0.57

ALTMAN Z-

CURR RATIO8.22

ND/EBITDA-

BETA2.61

FAQ

What is LOPJLB’s current signal on IFRX?: LOPJLB’s latest quantitative signal on InflaRx N.V. (IFRX) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is IFRX in?: InflaRx N.V. (IFRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does InflaRx N.V. (IFRX) do?: InflaRx N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States. The company's focus on C5a stems from its critical role as an inflammatory mediator implicated in the progression of various autoimmune and inflammatory diseases. Its primary product candidate, vilobelim…

InflaRx N.V. (IFRX)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news

FAQ